Evidence for Tissue Toxicity in BALBc Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate

Abstract EN

Leishmaniasis remains a serious public health problem in developing countries without effective control, whether by vaccination or chemotherapy.

Part of the failure of leishmaniasis control is due to the lack of new less toxic and more effective drugs able to eliminate both the lesions and the parasite.

Oxiranes derived from naphthoquinones now being assayed are promising drugs for the treatment of this group of diseases.

The predicted pharmacokinetic properties and toxicological profiles of epoxy-α-lapachone and epoxymethoxy-lawsone have now been compared to those of meglumine antimoniate, and histological changes induced by these drugs in noninfected BALB/c mice tissues are described.

Effects of these compounds on liver, kidney, lung, heart, and cerebral tissues of healthy mice were examined.

The data presented show that both these oxiranes and meglumine antimoniate induce changes in all BALB/c mice tissues, with the lung, heart, and brain being the most affected.

Epoxymethoxy-lawsone was the most toxic to lung tissue, while most severe damage was caused in the heart by epoxy-α-lapachone.

Meglumine antimoniate caused mild-to-moderate changes in heart and lung tissues.